# OnCo record jonathan-rosenberg (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jonathan-rosenberg/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jonathan-rosenberg" ;
  schema:name "Jonathan E. Rosenberg"@en ;
  schema:description "Led the early enfortumab vedotin trials and the atezolizumab study that first brought immunotherapy to bladder cancer."@en ;
  schema:url <https://onco.cc/people/jonathan-rosenberg/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Rosenberg%20JE%5BAuthor%5D%20urothelial%20enfortumab> ;
  onco:tag "urothelial", "adc", "immunotherapy" ;
  schema:jobTitle "Chief, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0003-2637-4249> ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/nectin4/>, <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/atezolizumab/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/ev-302/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ev-302-nejm-2024/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .